Correlation Between Sino Biopharmaceutica and Bonus BioGroup
Can any of the company-specific risk be diversified away by investing in both Sino Biopharmaceutica and Bonus BioGroup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sino Biopharmaceutica and Bonus BioGroup into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sino Biopharmaceutical Ltd and Bonus BioGroup, you can compare the effects of market volatilities on Sino Biopharmaceutica and Bonus BioGroup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sino Biopharmaceutica with a short position of Bonus BioGroup. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sino Biopharmaceutica and Bonus BioGroup.
Diversification Opportunities for Sino Biopharmaceutica and Bonus BioGroup
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Sino and Bonus is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Sino Biopharmaceutical Ltd and Bonus BioGroup in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bonus BioGroup and Sino Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sino Biopharmaceutical Ltd are associated (or correlated) with Bonus BioGroup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bonus BioGroup has no effect on the direction of Sino Biopharmaceutica i.e., Sino Biopharmaceutica and Bonus BioGroup go up and down completely randomly.
Pair Corralation between Sino Biopharmaceutica and Bonus BioGroup
Assuming the 90 days horizon Sino Biopharmaceutica is expected to generate 55.88 times less return on investment than Bonus BioGroup. But when comparing it to its historical volatility, Sino Biopharmaceutical Ltd is 26.9 times less risky than Bonus BioGroup. It trades about 0.04 of its potential returns per unit of risk. Bonus BioGroup is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1.00 in Bonus BioGroup on September 14, 2024 and sell it today you would earn a total of 1.00 from holding Bonus BioGroup or generate 100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 66.67% |
| Values | Daily Returns |
Sino Biopharmaceutical Ltd vs. Bonus BioGroup
Performance |
| Timeline |
| Sino Biopharmaceutical |
| Bonus BioGroup |
Sino Biopharmaceutica and Bonus BioGroup Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sino Biopharmaceutica and Bonus BioGroup
The main advantage of trading using opposite Sino Biopharmaceutica and Bonus BioGroup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sino Biopharmaceutica position performs unexpectedly, Bonus BioGroup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bonus BioGroup will offset losses from the drop in Bonus BioGroup's long position.| Sino Biopharmaceutica vs. Institute of Biomedical | Sino Biopharmaceutica vs. Defence Therapeutics | Sino Biopharmaceutica vs. Aileron Therapeutics | Sino Biopharmaceutica vs. Enlivex Therapeutics |
| Bonus BioGroup vs. Sino Biopharmaceutical Ltd | Bonus BioGroup vs. Defence Therapeutics | Bonus BioGroup vs. Aileron Therapeutics | Bonus BioGroup vs. Enlivex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |